Processa Pharmaceuticals Inc (PCSA)
1.56
-0.10
(-6.02%)
USD |
NASDAQ |
Apr 18, 16:00
1.55
-0.01
(-0.64%)
After-Hours: 20:00
Processa Pharmaceuticals Free Cash Flow (Quarterly): -2.124M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.124M |
| September 30, 2023 | -1.764M |
| June 30, 2023 | -2.064M |
| March 31, 2023 | -2.114M |
| December 31, 2022 | -2.497M |
| September 30, 2022 | -2.974M |
| June 30, 2022 | -2.330M |
| March 31, 2022 | -1.803M |
| December 31, 2021 | -2.727M |
| September 30, 2021 | -1.553M |
| June 30, 2021 | -2.194M |
| March 31, 2021 | -2.244M |
| December 31, 2020 | -2.275M |
| September 30, 2020 | 0.0292M |
| June 30, 2020 | -0.3506M |
| March 31, 2020 | -0.5465M |
| December 31, 2019 | -0.6135M |
| September 30, 2019 | -0.7218M |
| June 30, 2019 | -0.8075M |
| March 31, 2019 | -0.6074M |
| December 31, 2018 | -0.464M |
| September 30, 2018 | -1.031M |
| June 30, 2018 | -1.164M |
| March 31, 2018 | -1.071M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.405M |
| September 30, 2017 | -0.1737M |
| June 30, 2017 | -0.0747M |
| March 31, 2017 | -0.0016M |
| December 31, 2016 | -0.007M |
| September 30, 2016 | 0.0167M |
| June 30, 2016 | -0.0026M |
| March 31, 2016 | -0.0504M |
| December 31, 2015 | -0.0461M |
| September 30, 2015 | -0.0472M |
| June 30, 2015 | -0.2765M |
| March 31, 2015 | -0.5035M |
| December 31, 2014 | -0.4409M |
| September 30, 2014 | -0.5502M |
| June 30, 2014 | -0.7101M |
| March 31, 2014 | -1.002M |
| December 31, 2013 | -0.4625M |
| September 30, 2013 | -0.7297M |
| June 30, 2013 | -0.775M |
| March 31, 2013 | -0.5992M |
| December 31, 2012 | -0.6622M |
| September 30, 2012 | -0.9005M |
| June 30, 2012 | -0.4679M |
| March 31, 2012 | -0.1962M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-2.974M
Minimum
Sep 2022
0.0292M
Maximum
Sep 2020
-1.667M
Average
-2.064M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| Panbela Therapeutics Inc | -3.08M |
| Vera Therapeutics Inc | -25.14M |
| Corbus Pharmaceuticals Holdings Inc | -6.009M |
| Ensysce Biosciences Inc | -1.802M |
| Elicio Therapeutics Inc | -- |